Atlas Trials

Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)

Clinical trial NCT04704063 · COMPLETED

Trial details

NCT number
NCT04704063
Sponsor
Yuen Kah Hay
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatic SteatosisNAFLD
Start date
2021-01-01
Primary completion
2023-08-15
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.